Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.30USD
24 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.30
Open
$2.31
Day's High
$2.35
Day's Low
$2.29
Volume
22,790
Avg. Vol
25,170
52-wk High
$6.35
52-wk Low
$1.96

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.444
Sep '18 0.00 -0.492
Jun '18 0.00 -1.129
Mar '18 0.00 -0.802
FY 2017 Dec '17 0.00 -0.688
Sep '17 0.00 -0.727
Jun '17 0.00 -0.989
Mar '17 0.00 -0.798
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.00 0.00 0.00 0.75
Quarter Ending Sep-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 1.10
Year Ending Dec-20 3 0.00 0.00 0.00 3.84
Earnings (per share)
Quarter Ending Jun-19 4 -0.56 -0.39 -0.71 -0.56
Quarter Ending Sep-19 4 -0.50 -0.40 -0.63 -0.52
Year Ending Dec-19 4 -2.12 -1.79 -2.40 -2.50
Year Ending Dec-20 4 -1.75 -1.31 -2.01 -2.34
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 110.36 63.23
P/E High - Last 5 Yrs. -- 162.01 56.19
P/E Low - Last 5 Yrs. -- 51.90 28.65
Beta 2.19 1.17 0.93
Price to Sales (TTM) -- 45.94 9.59
Price to Book (MRQ) 1.08 13.21 4.56
Price to Tangible Book (MRQ) 1.08 18.92 7.90
Price to Cash Flow (TTM) -- 73.57 43.77
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.53
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.72 2.98
Payout Ratio(TTM) -- 8.59 21.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 21.58 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 61.47 8.00
Sales - 5 Yr. Growth Rate -- 33.19 11.09
EPS (MRQ) vs Qtr. 1 Yr. Ago 35.51 -92.02 109.53
EPS (TTM) vs TTM 1 Yr. Ago 10.49 -- --
EPS - 5 Yr. Growth Rate -- 21.56 6.92
Capital Spending - 5 Yr. Growth Rate -- 25.44 7.60

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.80 2.67
Current Ratio (MRQ) 3.88 3.64 3.64
LT Debt to Equity (MRQ) 0.00 7.08 13.32
Total Debt to Equity (MRQ) 16.79 20.11 17.04
Interest Coverage (TTM) -7,960.14 10.95 27.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 26.66 50.43
Gross Margin - 5 Yr. Avg. -- 60.00 50.79
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -10.62 15.80
Operating Margin (TTM) -- -107.59 -1.67
Operating Margin - 5 Yr. Avg. -- -26.23 11.10
Pre-Tax Margin (TTM) -- -108.35 -2.51
Pre-Tax Margin - 5 Yr. Avg. -- -28.92 16.70
Net Profit Margin (TTM) -- -114.71 -6.44
Net Profit Margin - 5 Yr. Avg. -- -34.10 11.68
Effective Tax Rate (TTM) -- 19.92 22.85
Effective Tax Rate - 5 Yr. Avg. -- 19.58 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,336,677 769,871,685
Net Income/Employee (TTM) -867,882 1,804,870 88,657,173
Receivable Turnover (TTM) -- 2.36 5.21
Inventory Turnover (TTM) -- 2.33 3.63
Asset Turnover (TTM) 0.00 0.32 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -74.63 6.32 9.53
Return on Assets - 5 Yr. Avg. -57.50 6.24 10.46
Return on Investment (TTM) -93.55 7.96 11.76
Return on Investment - 5 Yr. Avg. -64.73 8.17 13.35
Return on Equity (TTM) -116.66 8.13 12.60
Return on Equity - 5 Yr. Avg. -80.71 9.29 14.83
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 13.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cidara Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.21 -15.66 18 97
13 Week -22.03 -30.03 16 81
26 Week -39.47 -43.46 18 15
52 Week -41.77 -47.00 32 43
YTD -2.13 -16.37 30 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 72.65%
# of Holders: 65
Total Shares Held: 20,207,607
3 Mo. Net Change: -2,555
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.